MYLE
LIVE

Serial Number

87205601

Owner

MEDFAR INTERNATIONAL INC.

Attorney

Bradley M. Stohry

First Use Date

Aug 31, 2011

Filing Date

Oct 17, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MYLE Trademark

Serial Number: 87205601 • Registration: 6279707

MYLE is a trademark filed by MEDFAR INTERNATIONAL INC. on October 17, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MEDFAR INTERNATIONAL INC. (8 trademarks)

Montréal (Québec) H3B2S7 , CA

Entity Type: 03

Trademark Details

Filing Date

October 17, 2016

Registration Date

March 2, 2021

First Use Anywhere

August 31, 2011

First Use in Commerce

June 30, 2016

Published for Opposition

October 27, 2020

Goods & Services

Software as a service (SAAS) services, namely, software for electronic medical records management; Software as a service (SAAS) services, namely, software for the management of health care clinics, namely, software for the management of patient files, patient registration, scheduling and appointments, bill generation and tracking, the management of patient data, medical notes, documents and digital medical imaging, the management of instant messages, the management of statistics and trend charts enabling the determination of patient profiles, patient demographics and clinic practices; Software as a service (SAAS) services, namely, software for instant messaging between physicians, patients, and other participants in the health care system; Software as a service (SAAS) services, namely, electronic medical record management software for use in automating, entering, accessing, querying, analyzing, and transmitting clinical data and medical practice data; Software as a service (SAAS) services, namely, software for managing the use and operation of an interactive database of medical and patient care data; Software as a service (SAAS) services, namely, software for instant messaging between physicians and other participants in the health care system with respect to orders for medical tests and procedures; Software as a service (SAAS) services, namely, software for providing interfaces between medical diagnostic devices and laboratory information systems; Software as a service (SAAS) services, namely, software for clinical decision support, namely, clinical indicators, medication management, risk factor evolution, cross-populational studies and statistics aimed at clinicians, patients, and other participants of the health care system; Technical support services, namely, troubleshooting of computer software problems; Design, development, implementation, integration, installation, deployment, management and maintenance of electronic medical records software; Data migration services; Training services in the field of electronic medical records software; (Based on 44(e)) Software as a service (SAAS) services, namely, providing an online portal featuring software that enables patients to communicate with the clinics, to access their medical record information, to manage their appointments, to access their drug prescriptions, labs and other medical records

Software, namely, software for electronic medical records management; Software, namely, software for the management of health care clinics, namely, software for the management of patient files, patient registration, scheduling and appointments, bill generation and tracking, the management of patient data, medical notes, documents and digital medical imaging, the management of instant messages, the management of statistics and trend charts enabling the determination of patient profiles, patient demographics and clinic practices; Software, namely, software for instant messaging between physicians, patients, and other participants in the health care system; Software, namely, electronic medical record management software for use in automating, entering, accessing, querying, analyzing, and transmitting clinical data and medical practice data; Software, namely, software for managing the use and operation of an interactive database of medical and patient care data; Software, namely, software for instant messaging between physicians and other participants in the health care system with respect to orders for medical tests and procedures; Software, namely, software for providing interfaces between medical diagnostic devices and laboratory information systems; Software, namely, software for clinical decision support, namely, clinical indicators, medication management, risk factor evolution, cross-populational studies and statistics aimed at clinicians, patients, and other participants of the health care system; Software, namely, for providing an online portal featuring software that enables patients to communicate with the clinics, to access their medical record information, to manage their appointments, to access their drug prescriptions, labs and other medical records

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 2, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 2, 2021 R.PR
ELECTRONIC RECORD REVIEW COMPLETE
Jan 25, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 11, 2020 ERRR
WITHDRAWN FROM ISSUE - EXAMINING ATTORNEY REQUEST
Nov 3, 2020 ISER
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 27, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 18, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 27, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 4, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 4, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 4, 2020 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 5, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 5, 2019 GNSL
SUSPENSION LETTER WRITTEN
Sep 5, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2019 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 23, 2019 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 19, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 19, 2019 REAP
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 19, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 19, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 19, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 19, 2019 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 21, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 21, 2018 GNSL
SUSPENSION LETTER WRITTEN
Aug 21, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 20, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 20, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 20, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 20, 2018 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 22, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 22, 2017 GNSL
SUSPENSION LETTER WRITTEN
Aug 22, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2017 CRFA
ASSIGNED TO LIE
Aug 18, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2017 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2017 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 13, 2017 TCCA
NOTICE OF PSEUDO MARK E-MAILED
Oct 21, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2016 NWOS
NEW APPLICATION ENTERED
Oct 20, 2016 NWAP